130 results
424B3
HOTH
Hoth Therapeutics Inc
22 Apr 24
Prospectus supplement
4:15pm
, (ii) in connection therewith, to use certain inventions and licensed materials and (iii) to practice certain patent rights for the treatment … the potential to successfully commercialize the product and generate revenue from the product. If the FDA determines that the product promotional materials
8-K
EX-10.1
HOTH
Hoth Therapeutics Inc
28 Mar 24
Hoth Therapeutics Announces Exercise of Warrants for $4.2 Million Gross Proceeds
7:00am
the date hereof (or such shorter period as the Company was required by law or regulation to file such material) (the foregoing materials, including
8-K
EX-10.1
cse9ocbd 3nn3cm
15 Sep 23
Hoth Therapeutics Announces $2.89 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:15pm
424B5
x5e6obvs2b7sr
14 Sep 23
Prospectus supplement for primary offering
5:24pm
8-K
6qbmfsu9a4zuj4es
16 Aug 23
Other Events
8:31pm
DEFA14A
qlqk9cht9m kho8
27 Jun 23
Additional proxy soliciting materials
4:22pm
8-K
2lgk42
6 Jun 23
Other Events
4:17pm
8-K
EX-10.4
m0yq57y0u18
30 Dec 22
Hoth Therapeutics Announces $10 Million Private Placement
4:15pm